Cargando…
Effect of Puerarin Regulated mTOR Signaling Pathway in Experimental Liver Injury
It is known that excessive hepatocellular apoptosis is a typical characteristic of hepatic disease, and is regulated by the mammalian target of rapamycin (mTOR) signaling pathway. As the main active component of Kudzu (Pueraria lobata) roots, which is frequently used to treat hepatic diseases, Puera...
Autores principales: | Zhou, Bu-Gao, Zhao, Hai-Mei, Lu, Xiu-Yun, Zhou, Wen, Liu, Fu-Chun, Liu, Xue-Ke, Liu, Duan-Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206176/ https://www.ncbi.nlm.nih.gov/pubmed/30405406 http://dx.doi.org/10.3389/fphar.2018.01165 |
Ejemplares similares
-
Erzhi Pill® Repairs Experimental Liver Injury via TSC/mTOR Signaling Pathway Inhibiting Excessive Apoptosis
por: Zhou, Bu-gao, et al.
Publicado: (2017) -
Commentary: Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor
por: Renna, Maurizio
Publicado: (2016) -
Erzhi Pill(®) Protected Experimental Liver Injury Against Apoptosis via the PI3K/Akt/Raptor/Rictor Pathway
por: Zhao, Hai-Mei, et al.
Publicado: (2018) -
Integrating network pharmacology and experimental verification to explore the mechanism of puerarin against oliguria in acute alcoholism
por: Wan, Mei-Xuan, et al.
Publicado: (2022) -
Calcium Dobesilate Restores Autophagy by Inhibiting the VEGF/PI3K/AKT/mTOR Signaling Pathway
por: Wang, Yue, et al.
Publicado: (2019)